Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study [NA]

View source ↗

Summary

A completed MASTER study evaluating safety and efficacy of the Ultimaster drug-eluting stent (TCD-10023) in patients with ST-segment elevation myocardial infarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ultimaster Drug-Eluting Stent (TCD-10023) (Sirolimus-eluting stent)

Snippet

Sponsor: Terumo Europe N.V. | Conditions: Acute ST Segment Elevation Myocardial Infarction | NA | Status: COMPLETED